Selected article for: "antibody response and disease control"
Author: Amiral, Jean; Vissac, Anne Marie; Seghatchian, Jerard
Title: Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?
  • Cord-id: dtldj5nc
  • Document date: 2020_5_3
    • ID: dtldj5nc
    Snippet: Covid-19 is characterized by weak symptoms in most affected patients whilst severe clinical complications, with frequent fatal issues, occur in others. Disease severity is associated with age and comorbidities. Understanding of viral infectious mechanisms, and antibody immune response, can help to better control disease progression. SARS-CoV-2 has a major impact on the Renin Angiotensin Aldosterone System (RAAS), through its binding to the membrane cellular glycoprotein, Angiotensin Converting E
    Document: Covid-19 is characterized by weak symptoms in most affected patients whilst severe clinical complications, with frequent fatal issues, occur in others. Disease severity is associated with age and comorbidities. Understanding of viral infectious mechanisms, and antibody immune response, can help to better control disease progression. SARS-CoV-2 has a major impact on the Renin Angiotensin Aldosterone System (RAAS), through its binding to the membrane cellular glycoprotein, Angiotensin Converting Enzyme-2 (ACE-2), then infecting cells for replication. This report hypothesizes the possible implication of an autoimmune response, induced by generation of allo- or autoantibodies to ACE-2, or to its complexes with viral spike protein. This could contribute to some delayed severe complications occurring in affected patients. We also propose a strategy for investigating this eventuality.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and liver heart: 1, 2
    • absence presence and low concentration: 1, 2, 3
    • absence presence and low molecular weight heparin: 1
    • ace enzyme and action mode: 1, 2
    • ace enzyme and acute hypercoagulability: 1
    • ace enzyme and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace enzyme and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace enzyme and liver heart: 1, 2, 3, 4, 5
    • ace enzyme and liver heart mainly lung: 1
    • ace enzyme and low lymphocyte: 1
    • ace enzyme and low molecular weight heparin: 1
    • ace polymorphism and acute respiratory distress syndrome: 1, 2, 3, 4
    • ace polymorphism and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • action mode and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6
    • action mode and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mode and liver heart: 1
    • action mode and low concentration: 1
    • acute hypercoagulability and low molecular weight heparin: 1, 2